The Impact of Locoregional Treatment on Response to Nivolumab in Advanced Platinum Refractory Head and Neck Cancer: The Need Trial.

Botticelli A, Mezi S, Pomati G, Sciattella P, Cerbelli B, Roberto M, Mammone G, Cirillo A, Cassano A, Di Dio C, Cortellini A, Pizzuti L, Ronzino G, Salati M, Vici P, Polimeni A, Merlano MC, Nuti M, Marchetti P

Open source

DOI
10.3390/vaccines8020191
Published
2020 Apr 20
Container
Vaccines
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/vaccines8020191,
  title = {The Impact of Locoregional Treatment on Response to Nivolumab in Advanced Platinum Refractory Head and Neck Cancer: The Need Trial.},
  author = {Botticelli A and Mezi S and Pomati G and Sciattella P and Cerbelli B and Roberto M and Mammone G and Cirillo A and Cassano A and Di Dio C and Cortellini A and Pizzuti L and Ronzino G and Salati M and Vici P and Polimeni A and Merlano MC and Nuti M and Marchetti P},
  year = {2020},
  journal = {Vaccines},
  doi = {10.3390/vaccines8020191},
  url = {https://doi.org/10.3390/vaccines8020191}
}

RIS

TY  - JOUR
TI  - The Impact of Locoregional Treatment on Response to Nivolumab in Advanced Platinum Refractory Head and Neck Cancer: The Need Trial.
AU  - Botticelli A
AU  - Mezi S
AU  - Pomati G
AU  - Sciattella P
AU  - Cerbelli B
AU  - Roberto M
AU  - Mammone G
AU  - Cirillo A
AU  - Cassano A
AU  - Di Dio C
AU  - Cortellini A
AU  - Pizzuti L
AU  - Ronzino G
AU  - Salati M
AU  - Vici P
AU  - Polimeni A
AU  - Merlano MC
AU  - Nuti M
AU  - Marchetti P
PY  - 2020
JO  - Vaccines
DO  - 10.3390/vaccines8020191
UR  - https://doi.org/10.3390/vaccines8020191
ER  - 

APA

A, B., S, M., G, P., P, S., B, C., M, R., G, M., A, C., A, C., C, D. D., A, C., L, P., G, R., M, S., P, V., A, P., MC, M., M, N., & P, M. (2020). The Impact of Locoregional Treatment on Response to Nivolumab in Advanced Platinum Refractory Head and Neck Cancer: The Need Trial.. Vaccines. https://doi.org/10.3390/vaccines8020191

Source records